Myeloproliferative disorders: the centrosome connection (Q36233843)

12 August 2017

1 reference

title

Myeloproliferative disorders: the centrosome connection (English)

1 reference

myeloproliferative disorders

12 August 2017

1 reference

Delaval B

1

1 reference

12 August 2017

Lelièvre H

series ordinal

2

1 reference

12 August 2017

Birnbaum D

series ordinal

3

1 reference

12 August 2017

1 October 2005

1 reference

12 August 2017

1 reference

12 August 2017

19

1 reference

12 August 2017

10

1 reference

12 August 2017

1739-1744

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403926

12 August 2017

0 references

cites work

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Molecular genetics of human leukemias: new insights into therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Tyrosine kinase fusion genes in chronic myeloproliferative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The oncogenic fusion protein-tyrosine kinase ZNF198/fibroblast growth factor receptor-1 has signaling function comparable with interleukin-6 cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Proteomic characterization of the human centrosome by protein correlation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

A new sequence motif linking lissencephaly, Treacher Collins and oral-facial-digital type 1 syndromes, microtubule dynamics and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Lis1 and doublecortin function with dynein to mediate coupling of the nucleus to the centrosome in neuronal migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The structure of the N-terminal domain of the product of the lissencephaly gene Lis1 and its functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

GMAP-210, A cis-Golgi network-associated protein, is a minus end microtubule-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

RET and NTRK1 proto-oncogenes in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

53BP1, a mediator of the DNA damage checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Role for Fes/Fps Tyrosine Kinase in Microtubule Nucleation through Its Fes/CIP4 Homology Domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Jamip1 (marlin-1) defines a family of proteins interacting with janus kinases and microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Signal transduction pathways in sarcoma as targets for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

A role for PML3 in centrosome duplication and genome stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Centrosome aberrations: cause or consequence of cancer progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

From polyploidy to aneuploidy, genome instability and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Managing the centrosome numbers game: from chaos to stability in cancer cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Requirement of a centrosomal activity for cell cycle progression through G1 into S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Centrosomes enhance the fidelity of cytokinesis in vertebrates and are required for cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The centrosome in vertebrates: more than a microtubule-organizing center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Aneuploidy, centrosome activity and chromosome instability in cells deficient in homologous recombination repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

The centrosome in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Centrosome amplification and the development of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

G1 cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403926

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403926

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference